Plasmid vaccine expressing granulocyte-macrophage colony-stimulating factor attracts infiltrates including immature dendritic cells into injected muscles.
Plasmid-encoded GM-CSF (pGM-CSF) is an adjuvant for genetic vaccines; however, little is known about how pGM-CSF enhances immunogenicity. We now report that pGM-CSF injected into mouse muscle leads to a local infiltration of potential APCs. Infiltrates reached maximal size on days 3 to 5 after injection and appeared in several large discrete clusters within the muscle. Immunohistological studies in muscle sections from mice injected with pGM-CSF showed staining of cells with the macrophage markers CD11b, Mac-3, IA(d)/E(d) and to the granulocyte marker GR-1 from day 1 through day 14. Cells staining with the dendritic cell marker CD11c were detected only on days 3 to 5. Muscles injected with control plasmids did not stain for CD11c but did stain for CD11b, Mac-3, IA(d)/E(d), and GR-1. No staining was observed with the APC activation markers, B7.1 or CD40, or with markers for T or B cells. These findings are consistent with the infiltrating cells in the pGM-CSF-injected muscles being a mixture of neutrophils, macrophages, and immature dendritic cells and suggest that the i.m. APCs may be enhancing immune responses to coinjected plasmid Ags. This hypothesis is supported by data showing that 1) separation of injections with pGM-CSF and Ag-expressing plasmid into different sites did not enhance immune responses and 2) immune enhancement was associated with the presence of CD11c+ cells in the infiltrates. Thus, pGM-CSF enhancement may depend on APC recruitment to the i.m. site of injection.
Haddad
D
D
Malaria Program, Naval Medical Research Center, Silver Spring, MD 20910, USA.
Ramprakash
J
J
Sedegah
M
M
Charoenvit
Y
Y
Baumgartner
R
R
Kumar
S
S
Hoffman
S L
SL
Weiss
W R
WR
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000235:genetics / Q000378:metabolism; D000818:Animals; D000953:Antigens, Protozoan / Q000008:administration & dosage / Q000235:genetics / Q000276:immunology; D002454:Cell Differentiation / Q000276:immunology; D002465:Cell Movement / Q000276:immunology*; D003713:Dendritic Cells / Q000737:chemistry / Q000276:immunology* / Q000378:metabolism / Q000473:pathology; D004306:Dose-Response Relationship, Immunologic; D005260:Female; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000008:administration & dosage* / Q000096:biosynthesis* / Q000235:genetics / Q000276:immunology; D007111:Immunity, Cellular / Q000235:genetics; D007150:Immunohistochemistry; D007273:Injections, Intramuscular; D007276:Injections, Intraventricular; D016167:Integrin alphaXbeta2 / Q000096:biosynthesis; D007700:Kinetics; D008198:Lymph Nodes / Q000737:chemistry / Q000276:immunology / Q000473:pathology; D051379:Mice; D008807:Mice, Inbred BALB C; D018482:Muscle, Skeletal / Q000166:cytology / Q000276:immunology*; D010957:Plasmids / Q000008:administration & dosage* / Q000276:immunology* / Q000378:metabolism; D010967:Plasmodium yoelii / Q000235:genetics / Q000276:immunology; D019444:Vaccines, DNA / Q000008:administration & dosage* / Q000276:immunology* / Q000378:metabolism
D000276:Adjuvants, Immunologic; D000953:Antigens, Protozoan; D016167:Integrin alphaXbeta2; D019444:Vaccines, DNA; D016178:Granulocyte-Macrophage Colony-Stimulating Factor